Growth Metrics

Regeneron Pharmaceuticals (REGN) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -25,782.97%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 41.33%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.33%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1.99%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 45.47%
10 Revolution Medicines 31.20 Bn 31.20 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.99%
Dec 31, 2025 -9.13%
Sep 30, 2025 5.32%
Jun 30, 2025 19.70%
Mar 31, 2025 -5.48%
Dec 31, 2024 -25.58%
Sep 30, 2024 -6.96%
Jun 30, 2024 -23.73%
Mar 31, 2024 -14.67%
Dec 31, 2023 -0.13%
Sep 30, 2023 6.35%
Jun 30, 2023 3.76%
Mar 31, 2023 9.71%
Dec 31, 2022 14.82%
Sep 30, 2022 25.78%
Jun 30, 2022 64.44%
Mar 31, 2022 29.22%
Dec 31, 2021 40.14%
Sep 30, 2021 40.47%
Jun 30, 2021 79.70%
Mar 31, 2021 34.36%
Dec 31, 2020 89.70%
Sep 30, 2020 30.57%
Jun 30, 2020 31.59%
Mar 31, 2020 35.97%
Dec 31, 2019 46.81%
Sep 30, 2019 37.18%
Jun 30, 2019 -0.20%
Mar 31, 2019 35.89%
Dec 31, 2018 74.74%
Sep 30, 2018 41.62%
Jun 30, 2018 41.81%
Mar 31, 2018 84.72%
Dec 31, 2017 24.36%
Sep 30, 2017 65.68%
Jun 30, 2017 57.80%
Mar 31, 2017 52.42%
Dec 31, 2016 36.56%
Sep 30, 2016 22.00%
Jun 30, 2016 28.85%
Mar 31, 2016 20.89%
Dec 31, 2015 -31.01%
Sep 30, 2015 1.90%
Jun 30, 2015 34.15%
Mar 31, 2015 81.71%
Dec 31, 2014 49.55%
Sep 30, 2014 45.39%
Jun 30, 2014 47.85%
Mar 31, 2014 48.05%
Dec 31, 2013 90.25%